BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 27570419)

  • 1. Management of gastric and duodenal neuroendocrine tumors.
    Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
    World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Other Gastric and Duodenal Neuroendocrine Tumors.
    Laird AM; Libutti SK
    Surg Oncol Clin N Am; 2020 Apr; 29(2):253-266. PubMed ID: 32151359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gastric neuroendocrine tumors].
    Alekberzade AV; Krylov NN; Lipnitskiy EM; Shakhbazov RO; Azari F
    Khirurgiia (Mosk); 2019; (12):111-120. PubMed ID: 31825351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of patients with neuroendocrine tumors of the esophagus, stomach, and duodenum].
    Shimizu N; Kaminishi M
    Nihon Geka Gakkai Zasshi; 2008 May; 109(3):147-51. PubMed ID: 18536318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric and duodenal neuroendocrine tumours.
    O'Toole D; Delle Fave G; Jensen RT
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):719-35. PubMed ID: 23582915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
    Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
    Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
    Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
    Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
    Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
    McCarthy DM
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine Tumors of the Stomach.
    Corey B; Chen H
    Surg Clin North Am; 2017 Apr; 97(2):333-343. PubMed ID: 28325190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of carcinoid tumors of the stomach, duodenum, and pancreas.
    Akerström G
    World J Surg; 1996 Feb; 20(2):173-82. PubMed ID: 8661814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric Neuroendocrine Tumor and Duodenal Gastrinoma With Chronic Autoimmune Atrophic Gastritis.
    Chen WC; Warner RRP; Harpaz N; Zhu H; Roayaie S; Kim MK
    Pancreas; 2019 Jan; 48(1):131-134. PubMed ID: 30531243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours.
    Exarchou K; Howes N; Pritchard DM
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1247-1267. PubMed ID: 32390152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Duodenal neuroendocrine tumors].
    Alekberzade AV; Krylov NN; Garmanova TN; Shahbazov R; Azari F; Zuykova KS; Litovchenko ED
    Khirurgiia (Mosk); 2019; (7):87-95. PubMed ID: 31355821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of gastric neuroendocrine tumours.
    Plöckinger U
    Wien Klin Wochenschr; 2007; 119(19-20):570-2. PubMed ID: 17985089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.
    Lee HE; Mounajjed T; Erickson LA; Wu TT
    Endocr Pathol; 2016 Sep; 27(3):259-67. PubMed ID: 27306997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: our experience: a case report.
    Cavallaro A; Zanghì A; Cavallaro M; Lo Menzo E; Di Carlo I; Di Vita M; Cardì F; Piccolo G; Di Mattia P; Cappellani A
    Int J Surg; 2014; 12 Suppl 1():S225-31. PubMed ID: 24862665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric neuroendocrine tumors.
    Delle Fave G; Capurso G; Annibale B; Panzuto F
    Neuroendocrinology; 2004; 80 Suppl 1():16-9. PubMed ID: 15477710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment.
    Hoffmann KM; Furukawa M; Jensen RT
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):675-97. PubMed ID: 16253893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms.
    Delle Fave G; O'Toole D; Sundin A; Taal B; Ferolla P; Ramage JK; Ferone D; Ito T; Weber W; Zheng-Pei Z; De Herder WW; Pascher A; Ruszniewski P;
    Neuroendocrinology; 2016; 103(2):119-24. PubMed ID: 26784901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 38.